semaglutide pdufa FDA accepts filing application for oral 25 mg, which if approved, would be the first oral GLP-1 treatment for obesity FDA Clears Semaglutide For Cardiac

Under The Mental Health Parity and Addiction Equity Act, health insurers are required to cover substance use disorder treatment similar to how they would any physical condition

To maximize the benefits, we recommend an initial commitment of 5 months

Quality, purity, dosing, and contamination are real concerns with gray-market suppliers

Many clients report benefits like: improved skin glow and texture over time better recovery and resilience improved sleep consistency (especially when sleep has been off) Because this is a longevity-style protocol, results are often gradual and cumulative especially when paired with consistent lifestyle habits

Bottom line is that GLP-1 drugs can support heart health, and evidence increasingly shows that benefit isnt solely explained by weight loss

It pairs that with pancreatitis, which it calls rare but serious, noting that sudden severe abdominal pain warrants immediate evaluation